Given the identification of ADAM10 as a candidate AD susceptibility gene, interfering with its trafficking and with its activity could represent a new potential pathogenic mechanism that should be investigated in minute details in new natural mouse models. This evidence concerns the gene ADAM10 and Alzheimer disease.